Applications Published 13 February 2002
Published: 1-Sep-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Form of administration for applying in body orifices
Bodmeier, Roland 1178777*
Granules containing a plant substance and method for producing the same
DBF 1178778*
Ophthalmic insert and method for sustained release of medication to the eye
Eyelab 1176779*
Multipart controlled release selective serotonin reuptake inhibitor formulations
Elan 1178780*
Multilayer pharmaceutical product for release in the colon
Roehm 1178781*
Transdermal therapeutic system (TTS) containing tolterodine
Schwarz-Pharma 1178782*
Device and method for increasing the trandermal permeation of medicaments
LTS Lohmann Therapie-Systeme 1178783*
New pharmaceutical combinations for NOS inhibitors
Pfizer 1178784*
Compsns and methods for identifying antigens which elicit an immune response
Wake Forest University 1178785*
Protein stabilised, pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
American Biosciences 1178786*
Pharmaceutical compsns for oral administration of phloroglucinol and preparation thereof
Promindus (Actions Promotionnelles dans l'Industrie et le Commerce) 1178787*
Novel diphenylethylene compounds
Calyx Therapeutics 1178788*
Method of treating eating disorders
Knoll 1178789*
Treatment to lower platelet adhesiveness
Knoll 1178790*
The use of a protein tyrosine kinase pathway inhibitor in the treatment of ocular disorders
Johns Hopkins University School of Medicine 1178791*
Aryl amides, compsns containing such compounds and methods of use
Merck 1178792*
Stable, solid pharmaceutical compsns containing enalapril maleate
Ranbaxy Laboratories 1178793*
Use of succinic acid derivatives to obtain a medicine for treating inflammation
Sanofi-Synthelabo 1178794*
DFMO and CELECOXIB in combination for cancer chemoprevention and therapy
Ilex Oncoclgy 1178795*
Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
Savvipharm 1178796*
Inhibitors of IMPDH enzyme
Vertex Pharmaceuticals 1178797*
Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
AstraZeneca 1178798*
Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
Laboratoires des Produits Ethiques Ethypharm 1178799*
Methods for treating neurodegenerative disorders using aspartyl protease inhibitors
The Regents of the University of California 1178800*
Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of prutitis, itching and inflammatory disorders
Valletta, Giampiero 1178801*
Cyclic amidines useful as NMDA NR2B antagonists
Merck 178802*
Opioid antagonists containing compsns for enhancing analgesic potency of tramadol and attenuating its adverse side effects
Pain Therapeutics; Albert Einstein College of Medicine of Yeshiva University 1178803*
Use of topical azathioprine to treat inflammatory bowel disorder
Mayor Foundation for Medical Research 1178804*
Novel synthesis and crystallisation of piperazine ring-containing compounds
Teva Pharmaceutical Industries; Teva Pharmaceutic als USA; Singer, Claude; Liberman, Anita 1178805*
Transdermal device for the application of testosterone or one of the derivatives thereof
Pierre Fabre Medicament 1178806*
Use of antiprogestagens in combined therapy
Akzo Nobel 1178807*
Pharmaceutical compsn
Leo Pharmaceutical Products 1178808*
Pharmaceutical compsn in unit form containing acetylsalicylic acid and cloipidogrel hydrogenosulphate
Sanofi-Synethelabo 1178809*
Use of bisphosphonic acids for treating angiogenesis
Novartis 1178810*
Electrolyte gels for maintaining hydration and rehydration
PTS Labs 1178811*
A method of identifying therapeutic compounds for a treatment of hepatic disorders
The University of Newcastle Research Associates 1178814*
Death domain containing receptors
Human Genome Sciences; The Regents of the University of Michigan 1178815*
Materials for soft tissue augmentation and methods of making and using same
Orentreich Foundation of the Advancement of Science 1178816*
Molecular interactions in haematopoietic cells
Arbor Vita 1178817*
A stable compsn comprising epidermal growth factor as an active ingredient
Dewoong Pharmaceutical 1178818*
Glutathione reductase for the therapy and prophylaxis of AIDS
Ansovini, Raffaele 1778819*
Methods of modulating FABH activity
SmithKline Beecham Crop; SmithKline Beecham plc 1178820*
Use of heparin-binding antagonists in the inhibition of bradykinin release
Novo Nordisk 1178821*
New vaccines formulations -2
Onyvax 1178822*
New vaccines formulations - 1
Onyvax 1178823*
Staphylococcus aureus antigen-containing whole cell vaccine
Nabi 1178824*
Adjuvant combination formulations
American Cyanamid 1178825*
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
Immunomedics 1178826*
Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating HIV infections
Hippocampe 1178827*
Death domain containing receptor 4
Human Genome Sciences; The Regents of the University of Michigan 1178828*
Human monoclonal antibody
SmithKline Beecham 1178829*
Cyanine and indocyanine dye bioconugates for biomedical applications
Mallinckrodt 1178830*
Combined method of treatment compising an aromatase inhibitor and a further biologically active compound
Pharmacia & Upjohn 1178831*
Novel medicament compsns, based on anticholinergically effective compounds and beta-mimetics
Boehringer Ingelheim Pharma 1178832*
Topical compsn for prostaglandin E 1? delivery
Nexmed Holdings 1178833*
Controlled release of growth factors from heparin containing matrices
ETH-Zurich and University of Zurich 1178834*
Compsns and methods for improved learning and memory
Princeton University 1178835*
Use of chimeric mutational vectors to change endogenous sequences in solid tissues
The Board of Trustees of the Leland S Stanford Junior University 1178836*
Method for enhancing the contrast produced by MRI
The Government of the United States, as represented by the Secretary of the Department of Health and Human Services 1178837*
Macromolecular carrier for drug and diagnostic agent delivery
The Regents of the University of California 1178838*
